Thanks @JCO_ASCO for highlighting our article on on age, IDH status, and prognosis in lower grade gliomas. Age >40 is a surrogate for IDH status but not an independent prognostic factor in IDH-mutant glioma and does not predict benefit from CRT. Age is not an indication for CRT.
Prognostic and Predictive Effect of Age in Molecularly Defined Lower-Grade Gliomas. Co-authored by @TonyWangMD.View quoted post on X
Read the full article. bit.ly/4g5e6gU